Neuropathix, Inc. Stock
Equities
NPTX
US64132Q1094
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 18-07-24 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-07-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 17-06-19 |
Timothy Scott
BRD | Director/Board Member | 71 | 18-07-24 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |